The biological tumor markers' myopia: a model with CA 125 and second-look in ovarian cancer. 1987

F Zanaboni, and G Accinelli, and P Colombo, and G Jelmoni, and C Morandi, and S Pedronetto, and R Sbernini, and G Bolis
III Department of Obstetrics and Gynecology, University of Milan, Italy.

Preoperative CA 125 levels were measured in 36 patients with advanced epithelial ovarian carcinoma in clinical response undergoing a second-look operation. All the patients had positive levels (greater than 35 U/ml) of this tumor marker at diagnosis. The correlation between antigen levels and disease status at surgery revealed a sensitivity of this assay of 0.55 (only 11/20 patients still with tumor had positive levels) and a specificity of 0.94 (15/16 patients with no tumor had less than 35 U/ml). The predictive value of a positive test was 0.92. This method unfortunately proved unable to recognize microscopic residual tumor burden, less than 0.5 cm.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002277 Carcinoma A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for "cancer." Carcinoma, Anaplastic,Carcinoma, Spindle-Cell,Carcinoma, Undifferentiated,Carcinomatosis,Epithelial Neoplasms, Malignant,Epithelioma,Epithelial Tumors, Malignant,Malignant Epithelial Neoplasms,Neoplasms, Malignant Epithelial,Anaplastic Carcinoma,Anaplastic Carcinomas,Carcinoma, Spindle Cell,Carcinomas,Carcinomatoses,Epithelial Neoplasm, Malignant,Epithelial Tumor, Malignant,Epitheliomas,Malignant Epithelial Neoplasm,Malignant Epithelial Tumor,Malignant Epithelial Tumors,Neoplasm, Malignant Epithelial,Spindle-Cell Carcinoma,Spindle-Cell Carcinomas,Tumor, Malignant Epithelial,Undifferentiated Carcinoma,Undifferentiated Carcinomas
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000951 Antigens, Neoplasm Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin. Neoplasm Antigens,Tumor Antigen,Tumor Antigens,Antigen, Tumor,Antigens, Tumor
D015295 Antigens, Tumor-Associated, Carbohydrate Carbohydrate antigens expressed by malignant tissue. They are useful as tumor markers and are measured in the serum by means of a radioimmunoassay employing monoclonal antibodies. Antigens, Carbohydrate, Tumor-Associated,CA Antigens,Cancer-Associated Carbohydrate Antigens,Carbohydrate Antigens, Tumor-Associated,Tumor-Associated Carbohydrate Antigens,Antigen, Carcinoma-Associated,CA Antigen,CA(Oxford) Antigen,Carcinoma-Associated Antigen,Epitectin,Antigen, CA,Antigen, Carcinoma Associated,Antigens, CA,Antigens, Cancer-Associated Carbohydrate,Antigens, Tumor-Associated Carbohydrate,Cancer Associated Carbohydrate Antigens,Carbohydrate Antigens, Cancer-Associated,Carbohydrate Antigens, Tumor Associated,Carcinoma Associated Antigen,Tumor Associated Carbohydrate Antigens

Related Publications

F Zanaboni, and G Accinelli, and P Colombo, and G Jelmoni, and C Morandi, and S Pedronetto, and R Sbernini, and G Bolis
February 1986, American journal of obstetrics and gynecology,
F Zanaboni, and G Accinelli, and P Colombo, and G Jelmoni, and C Morandi, and S Pedronetto, and R Sbernini, and G Bolis
May 1986, Obstetrics and gynecology,
F Zanaboni, and G Accinelli, and P Colombo, and G Jelmoni, and C Morandi, and S Pedronetto, and R Sbernini, and G Bolis
December 1987, Geburtshilfe und Frauenheilkunde,
F Zanaboni, and G Accinelli, and P Colombo, and G Jelmoni, and C Morandi, and S Pedronetto, and R Sbernini, and G Bolis
January 1988, Oncology,
F Zanaboni, and G Accinelli, and P Colombo, and G Jelmoni, and C Morandi, and S Pedronetto, and R Sbernini, and G Bolis
February 1995, Annals of medicine,
F Zanaboni, and G Accinelli, and P Colombo, and G Jelmoni, and C Morandi, and S Pedronetto, and R Sbernini, and G Bolis
September 1991, American journal of obstetrics and gynecology,
F Zanaboni, and G Accinelli, and P Colombo, and G Jelmoni, and C Morandi, and S Pedronetto, and R Sbernini, and G Bolis
December 1988, European journal of cancer & clinical oncology,
F Zanaboni, and G Accinelli, and P Colombo, and G Jelmoni, and C Morandi, and S Pedronetto, and R Sbernini, and G Bolis
April 1985, American journal of obstetrics and gynecology,
F Zanaboni, and G Accinelli, and P Colombo, and G Jelmoni, and C Morandi, and S Pedronetto, and R Sbernini, and G Bolis
January 1988, Archives of gynecology and obstetrics,
F Zanaboni, and G Accinelli, and P Colombo, and G Jelmoni, and C Morandi, and S Pedronetto, and R Sbernini, and G Bolis
August 1986, Geburtshilfe und Frauenheilkunde,
Copied contents to your clipboard!